pillbase.ru

Entyvio

Active substance: vedolizumab

vedolizumab

Centralised EU authorisationActive

Marketing holder: Takeda Pharma A/S

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 3
  • ENTYVIO
    INJECTION, SOLUTION · VEDOLIZUMAB 108 mg/.68mL
    64764-107
    Takeda Pharmaceuticals America, Inc.
  • ENTYVIO Pen
    INJECTION, SOLUTION · VEDOLIZUMAB 108 mg/.68mL
    64764-108
    Takeda Pharmaceuticals America, Inc.
  • Entyvio
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · VEDOLIZUMAB 300 mg/5mL
    64764-300
    Takeda Pharmaceuticals America, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208d-7440-7452-833b-24513b947dd1,01a12092-492f-7f92-b7ec-0060ed2aaab2,01a1209b-8c47-75b4-86de-6add5ec9cf66;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/002782
Registration status
Active
Sources
  • product · EMA · EMEA/H/C/002782 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/002782 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/002782 · Verified 2026-10-09